This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SanDiego-based venture capital firm EnterprisePartners is one of the firms in a $39M, Series E funding round for Mountain View-based Complete Genomics , Complete Genomics said today. Illumina and Solexa, the firm Illumina acquired on August 3rd, have sued Complete Genomics on patent infringement of three patents.
One of the portfolio firms of SanDiego venture capital firm EnterprisePartners is heading towards an IPO, according to a S-1 filing Friday. Enterprise has been an investor in Complete Genomics since 2006, when it was a Series A investor in the firm.
One of the portfolio firms of SanDiego-based venture capital firm EnterprisePartners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. EnterprisePartners owns about 14.8 According to a filing from Complete Genomics, it will sell 6 million shares at $9.00
Anzu Partners , a venture capital and private equity investors focused on industrial technology with offices in the SanDiego area, has quietly raised $128.4M Among Anzu's Venture Partners is Carl Eibl, former Managing Partner at EnterprisePartners in SanDiego, and Vice Chairman of CONNECT; Eibl is based in SanDiego.
SanDiego-based Celladon , a clinical stage biopharmaceuticals firm which is developing enzymes to address calcium regulation, has filed for an IPO. Celladon is backed by EnterprisePartners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others.
SanDiego-based ecoATM , a developer of automated kiosks for recycling cell phones and other electronics, said this morning that it has raised a first institutional round of funding. The round came from TAO Venture Partners, the new venture firm run by Tom Clancy. Clancy was previously managing director at EnterprisePartners.
SanDiego-based XIFIN , which develops cloud-based financial software for the healthcare industry, has acquired Irvine-based PathCentral , a developer of software for the pathology community, the company announced Thursday afternoon. XIFIN''s investors include Boulder Ventures, EnterprisePartners, and Windward Ventures.
SanDiego-based XIFIN , a developer of revenue cycle management software-as-a-service for the healthcare industry, said Monday that it has named Craig Kussman as Chief Financial Officer at the firm. Kussman has previously served at Breach Security, Ascenta Therapeutics, Discovery Partners International, Inc., SYNAVANT Inc.,
SanDiego led investment activity in Q3, with a large number of the biggest VC deals all located in the area. Intellikine in La Jolla and Zogenix in SanDiego both raised $51M in deals; SanDiego's NextWave Wireless raised $45.5M, San Dieg's Roka BioScience $37.2M, and Borrego Solar Systems, in El Cajon, raised $30M.
SanDiego-based Celladon , a biopharmaceuticals firm developing a genetically targeted enzyme replacement therapy which helps in the treatment of late-stage, heart failure, has raised $53M in a second close of a funding round, the firm said today. and Venrock. and Venrock.
SanDiego- and Cupertino-based ParAccel , a developer of software for massively parallel databases used for data warehousing analytics, announced today that it has raised $22M in a venture capital round. Notably missing from this venture round for the firm was EnterprisePartners, an early backer of the firm.
SanDiego-based XIFIN , a developer of cloud-based software for the healthcare diagnostics market, has been acquired by private equity investor GTCR. XIFIN''s backers include Boulder Ventures, EnterprisePartners, and Windward Ventures. Financial terms of the buy were not disclosed. READ MORE>>.
SanDiego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M. The firm was advised by Peter J.
SanDiego-based VMIX , which provides software-as-a-service for video hosting, has raised $2.0M The filing shows representatives from JK&B Capital, Mission Ventures, ATA Ventures, and EnterprisePartners--all prior investors in the firm--remain on the board of directors.
SanDiego-based ParAccel, which develops database appliances used to accelerate database queries, said today that it has doubled its workforce over the past year, and has moved into new offices.
in SanDiego. The largest deals included $150M received by LA's Zestcash , $91.96M invested in SanDiego's Sapphire Energy , and $85M invested in Irvine's Alteryx. The PwC/NVCA MoneyTree report, which uses data from Thomson Reuters, tallied $693.17M in deals in the Los Angeles region; $276.1M
SanDiego- and Baltimore-based private equity investor JMI Equity is the lead backer of a developer of artificial intelligence software for the healthcare industry this morning. The funding was led by JMI Equity, and also included Health EnterprisePartners (HEP) and Health Velocity Capital (HVC). READ MORE>>.
SanDiego was not far behind, with $222.4M For Southern California, Orange County actually had the most dollars invested, with $239.6M invested across 18 deals, followed by Los Angeles, with $224.4M across 31 days. in 29 venture capital deals for Q1. invested in electric auto maker Fisker Automotive.
SanDiego-based VMIX , a provider of software for managing online video, said this morning that the firm has signed on automotive brand Scion. VMIX is venture backed by JK&B Capital and ATA Ventures, Mission Ventures and EnterprisePartners. Financial impact of the win was not disclosed. READ MORE>>.
SanDiego-based Scoperta , which is developing fabless specialty steel technology utilizing scrap materials, has raised $1.4M Other details on the funding have not been released, however, the firm is backed by EnterprisePartners and Vista Ventures, and Drew Senyei of Enterprise sits on the firm's board of directors.
In the region, SanDiego led in Q3 deals, with $236.3M The biggest deals in the quarter came for SanDiego's Roka Bioscience , with a $37.2M round; SanDiego-based Zogenix with a nearly $36M funding round; and Hawthorne-based Space Exploration Technology (SpaceX) , which raised $30.4M. in 25 deals.
SanDiego-based VMIX , which provides a platform for publishing and managing online video, reports today that it has signed on an ad agency and reseller, which has resulted in more than 30 customers for the firm. The firm is backed by JK&B Capital, ATA Ventures, Mission Ventures and EnterprisePartners. READ MORE>>.
SanDiego-based VMIX, a provider of video publishing tools for web publishers, said today that the firm has shuffled its executive staff and delivered a new version of its VMIX Player. The company is venture backed by ATA Ventures, EnterprisePartners, JK&B Capital, and Mission Ventures. READ MORE>>
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content